Etomidate Liposomal Injection from Japan
Advanced liposomal formulation of etomidate reducing injection site pain, in 20mL vials. Classified HTS 3004.90.92.37 as mixed product containing etomidate for measured sedative-hypnotic CNS therapy.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide liposome size distribution and encapsulation efficiency certificates
• Ensure glass vial compatibility with lipid carriers
• Monitor for cold chain breaks affecting liposome stability